Leptomeningeal metastasis
Showing 1 - 25 of 1,827
Leptomeningeal Metastasis Trial in Aarhus (CSI)
Not yet recruiting
- Leptomeningeal Metastasis
- CSI
-
Aarhus, DenmarkAarhus University Hospital
Feb 28, 2023
NSCLC, Epidermal Growth Factor Receptor, Leptomeningeal Metastasis Trial (Pemetrexed)
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- +2 more
- (no location specified)
Mar 27, 2023
NSCLC Trial in Chongqing (Aumonertinib 165mg orally once daily and intrathecal chemo with pemetrexed)
Recruiting
- Non-small Cell Lung Cancer
- Aumonertinib 165mg orally once daily and intrathecal chemotherapy with pemetrexed
-
Chongqing, Chinachongqing University Three Gorges Hospital
Apr 11, 2023
Leptomeningeal Metastasis, Immune Checkpoint Inhibitor, Endostatin Trial in Hebei (Camrelizumab or envafolimab)
Recruiting
- Leptomeningeal Metastasis
- +2 more
- Camrelizumab or envafolimab
-
Hebei, ChinaThe Second Hospital of Hebei Medical University
May 19, 2022
Leptomeningeal Metastases Trial in Changchun (Pemetrexed (1), Pemetrexed (2), Folic Acid)
Recruiting
- Leptomeningeal Metastases
- Pemetrexed (1)
- +4 more
-
Changchun, Jilin, ChinaThe First Hospital of Jilin University
Sep 29, 2022
Breast Cancer Metastatic, Leptomeningeal Metastasis Trial (Tucatinib Oral Tablet, Capecitabine tablets, Trastuzumab Injection)
Not yet recruiting
- Breast Cancer Metastatic
- Leptomeningeal Metastasis
- Tucatinib Oral Tablet
- +2 more
- (no location specified)
Mar 23, 2023
Non-small Cell Lung Cancer With Central Nervous System
Recruiting
- Lung Cancer With Central Nervous System Metastasis
- lung cancer with brain /leptomeningeal metastasis
-
Taipei, TaiwanNational Taiwan University Hospital
Sep 4, 2023
Leptomeningeal Metastasis Trial in Changchun (Pemetrexed, Radiotherapy)
Recruiting
- Leptomeningeal Metastasis
- Pemetrexed
- Radiotherapy
-
Changchun, Jilin, ChinaThe First Hospital of Jilin University
Jun 8, 2022
Leptomeningeal Metastasis, NSCLC Stage IV, Melanoma Stage IV Trial in Geneva, St Gallen, Zurich (intrathecal nivolumab and
Recruiting
- Leptomeningeal Metastasis
- +2 more
- intrathecal nivolumab and intrathecal ipilimumab
-
Geneva, Switzerland
- +2 more
Dec 18, 2022
Leptomeningeal Metastasis, Solid Tumor, Adult Trial in United Kingdom, United States (radiolabeled DPTA-omburtamab)
Withdrawn
- Leptomeningeal Metastasis
- Solid Tumor, Adult
- radiolabeled DPTA-omburtamab
-
Los Angeles, California
- +7 more
Jul 12, 2022
HER2-positive Breast Cancer, Leptomeningeal Metastasis, Leptomeningeal Disease Trial in Tampa, Evanston (Radiation Therapy,
Recruiting
- HER2-positive Breast Cancer
- +2 more
- Radiation Therapy
- +2 more
-
Tampa, Florida
- +1 more
Dec 30, 2022
Patients With Leptomeningeal Metastases ((LM) Using CNSide
Recruiting
- Leptomeningeal Metastasis
- +4 more
- CNSide
-
Los Angeles, CaliforniaValkyrie Clinical Trials
Sep 7, 2022
Brain Cancer, Glioblastoma, Metastatic Cancer Trial in New York (Trastuzumab deruxtecan)
Recruiting
- Brain Cancer
- +4 more
- Trastuzumab deruxtecan
-
New York, New YorkMemorial Sloan Kettering Cancer Center (All Protocol Activities)
Sep 22, 2023
NSCLC Associated With Leptomeningeal Metastases Trial (Tislelizumab, pemetrexed)
Not yet recruiting
- NSCLC Associated With Leptomeningeal Metastases
- Tislelizumab, pemetrexed
- (no location specified)
Nov 21, 2023
NSCLC, EGFR Activating Mutation, Brain Metastases Trial in Beijing (TY-9591 Tablets)
Recruiting
- NSCLC
- +3 more
- TY-9591 Tablets
-
Beijing, Beijing, ChinaNational Cancer Center/Cancer Hospitial,Chinese Academy of Medic
May 14, 2022
Leptomeningeal Metastases Trial in United States (Deferoxamine (DFO))
Recruiting
- Leptomeningeal Metastases
- Deferoxamine (DFO)
-
Basking Ridge, New Jersey
- +6 more
Jun 27, 2022
Breast Cancer, Leptomeningeal Metastasis Trial in Lille (Cerebrospinal fluid and blood sample collection at the initial
Withdrawn
- Breast Cancer
- Leptomeningeal Metastasis
- Cerebrospinal fluid and blood sample collection at the initial diagnostic assessment
- +2 more
-
Lille, Hauts-de- France, France
- +1 more
Oct 5, 2021
NSCLC, Brain Metastases, Leptomeningeal Metastasis Trial in Zhengzhou (almonertinib, LM-first line treatment, LM-second line
Recruiting
- NSCLC
- +2 more
- almonertinib
- +2 more
-
Zhengzhou, Henan, ChinaHenan Cancer Hospital
Aug 25, 2021
Non Small Cell Lung Cancer Trial in Hangzhou (Furmonertinib Mesilate Tablets)
Enrolling by invitation
- Non Small Cell Lung Cancer
- Furmonertinib Mesilate Tablets
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital, College of Medicine, Zhejiang Uni
Apr 3, 2023
Breast Carcinoma, Metastatic Malignant Tumor in the Brain, Metastatic Malignant Tumor in the Leptomeninges Trial in Chicago
Not yet recruiting
- Breast Carcinoma
- +2 more
- Biospecimen Collection
- +6 more
-
Chicago, IllinoisNorthwestern University
Nov 14, 2023
NSCLC, Leptomeningeal Metastasis, EGFR Activating Mutation Trial in Nanchang (Almonertinib, Bevacizumab)
Not yet recruiting
- NSCLC
- +2 more
-
Nanchang, Jiangxi, ChinaThe Second Afiliated Hospital of Nanchang University
Jun 26, 2021
Leptomeningeal Metastases Trial in United States (Involved-field Photon Radiation Therapy, Proton Craniospinal Irradiation
Active, not recruiting
- Leptomeningeal Metastases
- Involved-field Photon Radiation Therapy
- +3 more
-
Basking Ridge, New Jersey
- +7 more
Jul 22, 2022
Metastatic Breast Cancer, Leptomeningeal Disease Trial in Baltimore, Saint Louis, Winston-Salem (High-dose Methotrexate (8
Recruiting
- Metastatic Breast Cancer
- Leptomeningeal Disease
- High-dose Methotrexate (8 gm/m2; HD-MTX)
-
Baltimore, Maryland
- +2 more
May 5, 2022
Brain Metastases, Leptomeningeal Metastasis Trial in United States (GDC-0084, whole brain radiation therapy radiation)
Recruiting
- Brain Metastases
- Leptomeningeal Metastasis
- GDC-0084
- whole brain radiation therapy radiation
-
Miami, Florida
- +9 more
Jan 3, 2023